Why the study?
Do coagulation test abnormalities correlate with tumour burden and predict postoperative DVT in patients with colorectal cancer?
Do coagulation test abnormalities correlate with tumour burden and predict postoperative DVT in patients with colorectal cancer?
Answers are grounded in this paper and cite their sources.
Postoperative, but not preoperative, elevations in coagulation markers (F1+2, TAT, SF) are predictive of postoperative deep venous thrombosis in patients undergoing resection for colorectal cancer.
In a prospective study, coagulation test results were compared in 137 patients with colorectal cancer (CRC) and 39 subjects with benign colorectal diseases. Prothrombin fragment 1+2 (F1+2), thrombin-antithrombin complex (TAT), and soluble fibrin (SF) were measured in plasma before and after surgery. CRC patients presented with significantly higher values of F1+2 and TAT than controls. Patients with localised CRC had elevated values of F1+2 and TAT, whereas patients with advanced CRC also had elevated SF values. TAT and SF levels correlated with tumour spread, and normal values virtually excluded advanced cancer. Postoperative deep venous thrombosis (DVT) was diagnosed by phlebography in 20% of the CRC patients. Preoperative values of the markers did not predict postoperative DVT, but postoperative values did.
No takes yet. Share an insight, caveat, or question.
Thorlacius‐Ussing et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: